Schedule 13G ownership disclosure

ACELRX PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00444T100

Event date: 2018-05-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,746,817
Percent of class
7.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-037041
Form type
SC 13G
Filer
TALPHERA, INC.
CIK
CIK 1427925
Filed
May 31, 2018
Reporting period
May 21, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub